News
Abstract highlighting new preclinical data from LP-50 in non-muscle invasive bladder cancer

29 May 2024

News
BEND, Ore., May 28, 2024 - PRISM MediaWire - BranchOut Food Inc. (NASDAQ: BOF), a leading food technology company specializing in dehydrated fruit and vegetable-based products, has completed a successful shelf-life test through a strategic collaboration with the U.S. Arm...

28 May 2024

News
HAUPPAUGE, NY, May 24, 2024 - PRISM MediaWire - AmpliTech Group, Inc. (Nasdaq: AMPG, AMPGW), announced today that it received a notice of non-compliance from the Nasdaq Stock Market on May 22, 2024 notifying the company that, as a result of its failure to timely file its...

24 May 2024

News
BEND, Ore., May 24, 2024 - PRISM MediaWire - BranchOut Food Inc. (NASDAQ: BOF), a leading food technology company specializing in dehydrated fruit and vegetable-based products, today announced the expansion of its agreement with EnWave Corporation (TSX-V: ENW | FSE: E4U)...

24 May 2024

News
NEW YORK, NY, May 23, 2024 — PRISM MediaWire - JP 3E Holdings, Inc. (OTC: SPZI), formerly known as Spooz, Inc., is excited to announce the signing of an agreement to acquire a majority ownership interest in Bloxcross, Inc. ("BLOX"). Bloxcross is a trailblazing digital as...

23 May 2024

News
LAS VEGAS, NEVADA, May 23, 2024 – Avant Technologies, Inc. (OTCQB: AVAI) (“Avant” or the “Company”), a leading innovator and enabler of AI infrastructure technology, announces its engagement with Wired4Tech, a renowned AI infrastructure consulting firm.

23 May 2024

News
CLEARWATER, FL, May 22, 2024 — PRISM MediaWire - Power Engineering Corporation (PEC), a subsidiary of JP 3E Holdings, Inc., formerly Spooz, Inc. (OTC: SPZI) announces a joint venture with Bloxcross (BLOX) to expand business operations in the Middle East and North Africa ...

22 May 2024

News
Divestiture includes five non-core or under-performing properties

22 May 2024

News
Acquisition and expansion into payment processing expected to close before May 31, 2024

21 May 2024

News
Company to initiate Phase 2b clinical trial in lead asset, LP-10 in 2H 2024

21 May 2024

29
30
31
32
33
34
35
We use cookies to run our website, analyze your use of our services, manage your online preference & personalize ad content. By accepting our cookies, you’ll get relevant content and social media features, personalized ads, and an enhanced browsing experience. To manage your choices, click „Cookie Settings”. Necessary cookies are required for the core website functionality and cannot be rejected. For more information, see our Cookie Policy.
Cookie settings
Cookies used on the site are categorized and below you can read about each category and allow or deny some or all of them, except for Necessary Cookies which are required to provide core website functionality. When categories that have been previously allowed are disabled, all cookies assigned to that category will be removed from your browser. You can see a list of cookies assigned to each category and detailed information on those cookies in the “Cookie Policy” tab.
Necessary cookies
Some cookies are required to provide core functionality. The website won't function properly without these cookies and they are enabled by default and cannot be disabled.
Preferences
Preference cookies enables the website to remember information to customize how the website looks or behaves for each user. This may include storing selected currency region, language or color theme.
Analytical cookies
Analytical cookies help us improve our website by collecting and reporting information on its usage.
Marketing cookies
Marketing cookies are used to track visitors across websites to allow publishers to display relevant and engaging advertisements. By enabling marketing cookies, you grant permission for personalized advertising across various platforms.